BIOMAT Database Logo BIOMAT Database Logo

[Characteristics of viral infections in patients with chronic obstructive bronchitis]. 1987

N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia

Virological and immunological studies on 53 patients with chronic obstructive bronchitis at the clinical stage of fading exacerbation were conducted. A high percentage of active viral infection (43%), persistence of viruses (25%) and virus-specific components (ribonucleoprotein in influenza) in the cells of brush biopsy bronchial mucosa specimens was characteristic for these patients. The respiratory-syncytial virus was the most common persisting virus (11%). A high percentage of association (72%) of respiratory viruses (influenza, adenoviruses) and pneumonia Mycoplasma contributed to an increase in a period of an infective process. The utmost decrease in indices of cellular immunity (natural killer cell activity, T-cell and phagocytosis function) was detected in a group of patients with a prolonged (over 4 months) virus persistence.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009177 Mycoplasma pneumoniae Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man. Eaton Agent
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D010253 Respirovirus Infections Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface. Infections, Respirovirus
D011019 Pneumonia, Mycoplasma Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR. Mycoplasma Pneumonia,Pneumonia, Primary Atypical,Mycoplasma dispar Infection,Mycoplasma ovipneumoniae Infection,Mycoplasma pneumoniae Infection,Atypical Pneumonia, Primary,Atypical Pneumonias, Primary,Mycoplasma Pneumonias,Mycoplasma dispar Infections,Mycoplasma ovipneumoniae Infections,Mycoplasma pneumoniae Infections,Pneumonias, Mycoplasma,Pneumonias, Primary Atypical,Primary Atypical Pneumonia,Primary Atypical Pneumonias
D012136 Respiratory Syncytial Viruses A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported. Chimpanzee Coryza Agent,Orthopneumovirus,RSV Respiratory Syncytial Virus,Chimpanzee Coryza Agents,Coryza Agent, Chimpanzee,Orthopneumoviruses,Respiratory Syncytial Virus,Syncytial Virus, Respiratory,Virus, Respiratory Syncytial
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic

Related Publications

N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
Viral infections in patients with chronic obstructive pulmonary disease.
March 2008, Current opinion in pulmonary medicine,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
Comparison of clinical characteristics between chronic bronchitis and non-chronic bronchitis in patients with chronic obstructive pulmonary disease.
February 2022, BMC pulmonary medicine,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[Natural killer activity in a viral infection in patients with chronic obstructive bronchitis].
January 2000, Likars'ka sprava,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
Respiratory viral infections in patients with chronic, obstructive pulmonary disease.
May 2005, The Journal of infection,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[Recurrent respiratory infections in patients with chronic obstructive bronchitis: medical treatment and costs].
October 1996, Revue des maladies respiratoires,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[Treatment of patients with chronic obstructive bronchitis].
January 1995, Problemy tuberkuleza,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[Bacterial infections and the status of cellular immunity in patients with chronic obstructive bronchitis].
January 1987, Pneumonologia polska,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[Characteristics of the course of pulmonary hypertension in patients with chronic obstructive bronchitis (2)].
January 1988, Terapevticheskii arkhiv,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[Cytokine imbalance in patients with chronic obstructive bronchitis].
January 2003, Klinicheskaia meditsina,
N V Iakovleva, and I V Pokhodzeĭ, and M I Tovt-Korshinskaia, and O A Sukhovskaia
[The characteristics of treating patients with chronic obstructive bronchitis combined with chronic pancreatitis and biliary dyskinesia].
April 1991, Vrachebnoe delo,
Copied contents to your clipboard!